Turning CO2 into Carbon-Neutral Industrial Chemicals Evan Haas, Co-Founder & CEO, Helix Carbon Helix Carbon: https://helixcarbon.co/
Helix Carbon is decarbonizing heavy industry by transforming emitted CO2 into carbon-neutral fuels & chemicals including CO, ethylene, and syngas. Born from MIT innovations, these electrochemical systems use inexpensive catalysts with high stability to convert flue gas directly into these cost-competitive carbon feedstocks. Helix builds drop-in electrolyzers that integrate with existing direct reduced iron & petrochemical facilities to upcycle CO2 emissions into chemical feedstocks, enabling green steel, polycarbonate, polyurethane, and more.
Global Bank looking to MIT to help drive its digital journey for Risk & Controls framework, both at pace and at scale, with automated end-to-end processes and underlying key controls, positioning the bank as an industry leader in this space.
R&D Conference is our biggest conference of the year. We're looking for 10 speakers/exhibitors.
P&G Ventures is looking for startup submissions on disruptive solutions in women's wellness. P&G is on a mission to help women (18+) optimize/enhance their health and wellness by (a) creating products that are designed specifically for women, (b) address gaps in her self-care and (c) offer meaningful difference in her life. We will start by addressing frequent, daily fatigue that negatively impacts her day, her capacity and ultimately her relationships.
MIT Startup Exchange is looking for 15 MIT-connected startups to present at MIT Japan Conference Webinar Series and also participate in a Meet & Greet.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
xTechIgnite is a competition for eligible small businesses across the U.S. to engage with the Department of Defense (DoD), earn prize money and submit a Phase I or Direct to Phase II (D2PhII) Army Small Business Innovation Research (SBIR) proposal.
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.